dc.contributor.author |
Laufer, Stefan |
|
dc.contributor.author |
Bühler, Stefanie |
|
dc.date.accessioned |
2014-07-14T15:00:20Z |
|
dc.date.available |
2014-07-14T15:00:20Z |
|
dc.date.issued |
2014 |
|
dc.identifier.issn |
1354-3776 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/54370 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Informa Healthcare |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1517/13543776.2014.894977 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
540 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
P38 MAPK inhibitors: a patent review (2012-2013) |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20140610213910_00085 |
de_DE |
utue.publikation.seiten |
535-554 |
de_DE |
utue.personen.roh |
Buehler, Stefanie |
|
utue.personen.roh |
Laufer, Stefan A. |
|
dcterms.isPartOf.ZSTitelID |
Expert Opinion on Therapeutic Patents |
de_DE |
dcterms.isPartOf.ZS-Issue |
5 |
de_DE |
dcterms.isPartOf.ZS-Volume |
24 |
de_DE |
utue.fakultaet |
07 Mathematisch-Naturwissenschaftliche Fakultät |
de_DE |